112 related articles for article (PubMed ID: 23372116)
1. MMP-9 -1562 Promoter Polymorphism Associated with Gastric Cancer Risk in Females.
Lee TY; Yu CC; Wu CC; Chang CS; Lin JT; Wu MS; Chen HP; Wu CY
Hepatogastroenterology; 2013 Feb; 60(126):. PubMed ID: 23372116
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer.
Wu CY; Wu MS; Chen YJ; Chen CJ; Chen HP; Shun CT; Chen GH; Huang SP; Lin JT
Eur J Cancer; 2007 Mar; 43(4):799-808. PubMed ID: 17236757
[TBL] [Abstract][Full Text] [Related]
4. Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
Tang Y; Zhu J; Chen L; Chen L; Zhang S; Lin J
Clin Cancer Res; 2008 May; 14(9):2870-7. PubMed ID: 18451255
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-1 (MMP-1) Promoter polymorphisms are well linked with lower stomach tumor formation in eastern Indian population.
Dey S; Ghosh N; Saha D; Kesh K; Gupta A; Swarnakar S
PLoS One; 2014; 9(2):e88040. PubMed ID: 24505369
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of urokinase-type plasminogen activator genotypes in gastric cancer.
Wu CY; Wu MS; Chen YJ; Chen HP; Chen CJ; Chang CS; Lin JT
Hepatogastroenterology; 2008; 55(86-87):1890-4. PubMed ID: 19102416
[TBL] [Abstract][Full Text] [Related]
7. A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer.
Matsumura S; Oue N; Kitadai Y; Chayama K; Yoshida K; Yamaguchi Y; Toge T; Imai K; Nakachi K; Yasui W
J Cancer Res Clin Oncol; 2004 May; 130(5):259-65. PubMed ID: 14986114
[TBL] [Abstract][Full Text] [Related]
8. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer.
Matsumura S; Oue N; Nakayama H; Kitadai Y; Yoshida K; Yamaguchi Y; Imai K; Nakachi K; Matsusaki K; Chayama K; Yasui W
J Cancer Res Clin Oncol; 2005 Jan; 131(1):19-25. PubMed ID: 15565457
[TBL] [Abstract][Full Text] [Related]
9. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
11. MMP 9 Gene Promoter Polymorphism in Gastric Cancer.
Krishnaveni D; Bhayal AC; Sri Manjari K; Vidyasagar A; Uma Devi M; Ramanna M; Jyothy A; Nallari P; Venkateshwari A
Indian J Clin Biochem; 2012 Jul; 27(3):259-64. PubMed ID: 26405384
[TBL] [Abstract][Full Text] [Related]
12. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
14. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population].
Zhang XM; Miao XP; Xiong P; Yu CY; Tan W; Qu SN; Sun T; Zhou YF; Lin DX
Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer.
Lai HC; Chu CM; Lin YW; Chang CC; Nieh S; Yu MH; Chu TY
Gynecol Oncol; 2005 Feb; 96(2):314-9. PubMed ID: 15661214
[TBL] [Abstract][Full Text] [Related]
16. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
Srivastava P; Kapoor R; Mittal RD
Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of molecular detection of matrix metalloproteinase-1 in bone marrow and peripheral blood in patients with gastric cancer.
Kosaka Y; Mimori K; Fukagawa T; Ishikawa K; Etoh T; Katai H; Sano T; Watanabe M; Sasako M; Mori M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S430-7. PubMed ID: 21761103
[TBL] [Abstract][Full Text] [Related]
19. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
Hughes S; Agbaje O; Bowen RL; Holliday DL; Shaw JA; Duffy S; Jones JL
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6673-80. PubMed ID: 18006768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
